Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvs crawled date : 2021 - 08 - 03 save search
Pieris Pharmaceuticals Strengthens Executive R&D Leadership Team
Published: 2021-08-03 (Crawled : 13:00) - biospace.com/
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.3%
H: 0.17%
C: 0.17%
PIRS | $12.0 2.67% 2.6% 120K
|
Health Technology
|
| O: 1.42%
H: 2.38%
C: 1.96%
Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: -0.6%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.3%
H: 0.17%
C: 0.17%
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 0.55%
H: 1.32%
C: 1.03%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: -2.43%
H: 0.88%
C: 0.44%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: -0.7%
H: 0.31%
C: 0.04%
financial results results
Novartis announces lift of partial clinical trial hold and plans to initiate a new, pivotal Phase 3 study of intrathecal OAV-101 in older patients with SMA
Published: 2021-08-03 (Crawled : 06:00) - globenewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.3%
H: 0.17%
C: 0.17%
phase 3 trial order
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.